Preseeding of human vascular cells in decellularized bovine pericardium scaffold for tissue-engineered heart valve: An in vitro and in vivo feasibility study

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 6, 2012, Pages 1654-1661

  Yang, Min ^a,b   Chen, Chang Zhi ^b   Shu, Yu Sheng ^a   Shi, Wei Ping ^a   Cheng, Shao Fei ^b   John Gu, Y ^c  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

bovine pericardium; cell seeding; decellularization; heart valve; tissue engineering

Indexed keywords

BOVINE PERICARDIUM; CELL SEEDING; CELL SOURCES; COCULTURE; DECELLULARIZATION; DECELLULARIZED; FEASIBILITY STUDIES; HEART VALVES; HUMAN ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; IN-VITRO; IN-VIVO; NUDE MICE; SAPHENOUS VEIN; SEEDED CELLS; SMOOTH MUSCLE ACTINS; SMOOTH MUSCLE CELLS; SYNTHETIC SCAFFOLDS; TISSUE-ENGINEERED HEART; VASCULAR CELLS; VON WILLEBRAND FACTOR;

CELL CULTURE; ENDOTHELIAL CELLS; FIBROBLASTS; MAMMALS; PROTEINS; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; TISSUE SCAFFOLD; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SEEDING; COCULTURE; CONTROLLED STUDY; COW; DECELLULARIZED BOVINE PERICARDIUM; ENDOTHELIUM CELL; FEASIBILITY STUDY; FIBROBLAST; HEART VALVE PROSTHESIS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INCISION; MALE; MOUSE; NONHUMAN; PERICARDIUM; PROCEDURES CONCERNING CELLS; SAPHENOUS VEIN; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE FIBER; TISSUE ENGINEERED HEART VALVE; TISSUE ENGINEERING;

ANIMALS; BIOPROSTHESIS; CATTLE; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FIBROBLASTS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; MALE; MICE; MICE, NUDE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PERICARDIUM; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84863719206     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32734     Document Type: Article

References (33)

1. Schoen FJ,. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008; 118: 1864-1880.
2. Sacks MS, Schoen FJ, Mayer JE,. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 2009; 11: 289-313.
3. Schmidt D, Dijkman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, Rissanen M, Deichmann T, Odermatt B, Weber B, Emmert MY, Zund G, Baaijens FP, Hoerstrup SP,. Minimally-invasive implantation of living tissue engineered heart valves: A comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 2010; 56: 510-520.
4. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH,. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36: 1152-1158.
5. Kulik A, Bédard P, Lam BK, Rubens FD, Hendry PJ, Masters RG, Mesana TG, Ruel M,. Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg 2006; 30: 485-491.
6. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661.
7. Lund O, Bland M,. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg 2006; 132: 20-26.
8. Schoen FJ, Levy RJ,. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-1080.
9. Mendelson K, Schoen FJ,. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann Biomed Eng 2006; 34: 1799-1819.
10. Schmidt D, Stock UA, Hoerstrup SP,. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci 2007; 362: 1505-1512.
11. Haegerstrand A, Gillis C, Bengtsson L,. Serial cultivation of adult human endothelium from the great saphenous vein. J Vasc Surg 1992; 16: 280-285.
12. Schnell AM, Hoerstrup SP, Zund G, Kolb S, Sodian R, Visjager JF, Grunenfelder J, Suter A, Turina M,. Optimal cell source for cardiovascular tissue engineering: Venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 2001; 49: 221-225.
13. Gulbins H, Dauner M, Petzold R, Goldemund A, Anderson I, Doser M, Meiser B, Reichart B,. Development of an artificial vessel lined with human vascular cells. J Thorac Cardiovasc Surg 2004; 128: 372-377.
14. Mol A, Rutten MC, Driessen NJ, Bouten CV, Zünd G, Baaijens FP, Hoerstrup SP,. Autologous human tissue-engineered heart valves: Prospects for systemic application. Circulation 2006; 114 (1 Suppl): I152-I158.
15. Yang M, Chen CZ, Wang XN, Zhu YB, Gu YJ,. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater 2009; 91B: 354-361.
16. Gilbert TW, Sellaro TL, Badylak SF,. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-3683.
17. Schmidt D, Hoerstrup SP,. Tissue engineered heart valves based on human cells. Swiss Med Wkly 2006; 136: 618-623.
18. Rabkin-Aikawa E, Mayer JE Jr, Schoen FJ,. Heart valve regeneration. Adv Biochem Eng Biotechnol 2005; 94: 141-179.
19. Redmond EM, Cahill PA, Sitzmann JV,. Perfused transcapillary smooth muscle cell and endothelial cell co-culture: A novel in vitro model. In Vitro Cell Dev Biol 1995; 31: 601-609.
20. Williamson MR, Shuttleworth A, Canfield AE, Black RA, Kielty CM,. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. Biomaterials 2007; 28: 5307-5318.
21. Sato Y, Rifkin DB,. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309-315.
22. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S, Lawrence DA, Okada SS,. Endothelial cells inhibit flow-induced smooth muscle cell migration: Role of plasminogen activator inhibitor-1. Circulation 2001; 103: 597-603.
23. Sacks MS, Mirnajafi A, Sun W, Schmidt P,. Bioprosthetic heart valve heterograft biomaterials: Structure, mechanical behavior and computational simulation. Expert Rev Med Devices 2006; 3: 817-834.
24. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, Aranki SF, Couper GS, Cohn LH,. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: Up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010; 89: 1410-1416.
25. Gulbins H, Pritisanac A, Dauner M, Petzold R, Goldemund A, Doser M, Meiser B, Reichart B,. Seeding of human vascular cells onto small diameter polyurethane vascular grafts. Thorac Cardiovasc Surg 2006; 54: 102-107.
26. Schmidt CE, Baier JM,. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000; 21: 2215-2231.
27. Lai PH, Chang Y, Chen SC, Wang CC, Liang HC, Chang WC, Sung HW,. Acellular biological tissues containing inherent glycosaminoglycans for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng 2006; 12: 2499-2508.
28. Wei HJ, Liang HC, Lee MH, Huang YC, Chang Y, Sung HW,. Construction of varying porous structures in acellular bovine pericardia as a tissue-engineering extracellular matrix. Biomaterials 2005; 26: 1905-1913.
29. Hollister SJ,. Porous scaffold design for tissue engineering. Nat Mater 2005; 4: 518-524.
30. Manning DD, Reed ND, Shaffer CF,. Maintenance of skin xenografts of widely divergent phylogenetic origin of congenitally athymic (nude) mice. J Exp Med 1973; 138: 488-494.
31. Shultz LD, Sidman CL,. Genetically determined murine models of immunodeficiency. Annu Rev Immunol 1987; 5: 367-403.
32. Fortmeyer HP,. New experimental possibilities in nutritive oncology by the model of human tumors, xenotransplanted and passaged into athymic nude mice. Prog Clin Biol Res 1988; 259: 283-293.
33. Jin K, Teng L, Shen Y, He K, Xu Z, Li G,. Patient-derived human tumour tissue xenografts in immunodeficient mice: A systematic review. Clin Transl Oncol 2010; 12: 473-480.